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A recombinant HSV-1 virus expressing EGFP from the HCMV major immediate early promoter (KOS-CMVGFP) was constructed to monitor
viral replication and spread in vitro and in mice. KOS-CMVGFP replicated as efficiently as wild-type virus, strain KOS, in single cycle growth
experiments in Vero cells indicating that the recombinant virus has no significant growth defects in vitro. Following ocular inoculation of mice,
KOS-CMVGFP exhibited slight but statistically significant reductions in mouse tear film titers relative to wild-type virus. Progression of virus
infection of the eyes, periocular tissue, and snout was readily followed by fluorescence microscopy. Insertion of the EGFP expression cassette into
the KOS genome had no effect on the efficiency of establishment of latency as determined by quantitative competitive PCR of viral genomes in
latently infected TG. KOS-CMVGFP reactivated with wild-type kinetics and efficiency by explant cocultivation, but exhibited a significant delay
in the kinetics and a modest reduction in the efficiency of reactivation compared to KOS in the more sensitive TG cell culture model. Notably,
EGFP expression preceded the detection of infectious virus by greater than 24 h in both ex vivo models and thus is a useful marker of the early
stages in the induction of reactivation.
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Because of the broad host range of HSV-1, several animal
models are available to study viral infection in vivo. Two such
models, the rabbit and guinea pig, recreate to a limited extent all
aspects of HSV-1 infection in humans (i.e. acute replication,
establishment of latency, and reactivation), but at considerable
expense to the investigator. The mouse model is more widely
used because it is relatively inexpensive in that sufficient
numbers of animals can be purchased at a lower cost to achieve
statistically significant data. Unlike rabbits and guinea pigs,⁎ Corresponding author. Fax: +1 617 667 8540.
E-mail address: pschaffe@bidmc.harvard.edu (P.A. Schaffer).
1 Present address: Vaccine and Biologics Research Department, Merck
Research Laboratories, Merck and Co., Inc., West Point, PA 19486, USA.
0042-6822/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2006.11.022however, spontaneous reactivation in mice has not been
demonstrated (Feldman et al., 2002; Gebhardt and Halford,
2005). Therefore, reactivation is most commonly induced by
explanting trigeminal ganglia (TG), which contain the cell
bodies of latently infected neurons. In this case the stress
associated with explant induces reactivation.
In the mouse ocular model, mice are inoculated on the surface
of the eye following corneal scarification. Virus replication oc-
curs in corneal epithelial cells, keratocytes, and endothelial cells.
Virus then enters the termini of sensory neurons that innervate the
cornea and travels intraaxonally to neuronal cell bodies in TG
resulting in either (i) productive infection, characterized by
extensive viral gene expression, viral DNA replication, produc-
tion of infectious virus and cell death, or (ii) latency, charac-
terized by limited viral gene expression, the absence of viral
DNA replication, the failure to produce infectious virus, and
373J.W. Balliet et al. / Virology 361 (2007) 372–383neuronal survival. Although the factors that determine which
program is operative are not known, these opposing biological
endpoints, productive infection and latency, reflect the fact that
the neuron plays a central role in determining the outcome of
HSV-1 infection (Margolis et al., 1992a,1992b). Virus reaches
TG between 1 and 2 days post-inoculation and viral latency is
established within 2 weeks of corneal inoculation as determined
by the absence of infectious virus and the presence of viral DNA.
Traditionally, to examine the role of viral proteins or cis-
acting elements in the mouse ocular model, mutant viruses are
compared to wild-type virus with regard to (i) the efficiency of
viral replication in eyes and TG, (ii) the efficiency of the
establishment of latency, and (iii) the kinetics and frequency of
reactivation following TG explant. This and other similar
animal models have the disadvantage that infected animals must
be euthanized at specified times post-infection in order to
harvest tissue needed to determine the distribution and titers of
virus. Thus, the ability to monitor both the spread and ultimate
outcome of viral infection in the same animal is precluded. As a
means of circumventing this problem, recombinant viruses
expressing various reporter genes visible by eye have been used
to monitor the kinetics and extent of virus spread in animals.
LacZ (Escherichia coli), firefly luciferase (Photinus pyralis),
and enhanced green fluorescent protein (EGFP; Aequorea
victoria) (Cormack et al., 1996) are among the reporter genes
used to generate recombinant viruses. Relevant properties of
these reporter genes include the following: (i) to visualize
β-galactosidase, the product of the lacZ gene, chemical fixation
of cells prior to staining is required such that additional experi-
mentation with the same infected mouse cannot be performed;
(ii) in tests of noninvasive bioluminescent imaging in mice
infected by the ocular route with a recombinant HSV-1
expressing firefly luciferase, luminescence produced in TG
was indistinguishable from overlying periocular tissues in the
intact animal (Luker et al., 2002), thus rendering the firefly
luciferase reporter system undesirable for some purposes in the
mouse ocular model; (iii) unlike LacZ and firefly luciferase,
EGFP requires no cofactors or substrates for detection; (iv)
EGFP is resistant to heat, alkaline pH (Patterson et al., 1997),
detergents, chaotropic salts, organic solvents, and most pro-
teases; and (v) EGFP intensity in living cells can be quantified
by FACS (Soboleski et al., 2005), confocal scanning laser
microscopy, and fluorometric assays. For these reasons we have
constructed a recombinant of HSV-1, strain KOS, expressing
EGFP from the human cytomegalovirus major immediate early
promoter (HCMV-MIEP), termed KOS-CMVGFP. We describe
the construction and in vitro and in vivo characterization of
KOS-CMVGFP and demonstrate the utility of this virus for
studies of viral infection and pathogenesis in mice.
Results
Construction and isolation of a recombinant of HSV-1, strain
KOS, expressing EGFP
The strategy described by Cai et al. (1993) was used to
generate a recombinant of HSV-1, strain KOS, expressing highlevels of EGFP (Fig. 1). This strategy involved insertion of the
EGFP gene into the minimally and convergently transcribed
region between the UL26/26.5 and UL27 genes in the HSV-1
genome (Fig. 1C). Insertion at this location was thought to
have little or no effect on expression of adjacent viral genes
(Bzik et al., 1984; Holland et al., 1984; Liu and Roizman,
1991). As the first step in generating the virus, plasmid
pGFP53K was constructed (Figs. 1D and E). This plasmid
contains an expression cassette consisting of the HCMV-MIEP
(Brewer and Roth, 1991) driving EGFP. The SV40 late
polyadenylation signal was added to ensure efficient poly-
adenylation of the EGFP transcript. Viral DNA restriction
fragments consisting of an ∼1 kb SalI–FspI fragment, which
spans nucleotides 52,192 to 53,150 and contains a portion of
UL26 and UL26.5, and an ∼2 kb DraI–SalI fragment,
spanning nucleotides 52,764 to 54,826 and containing a
portion of UL27, were ligated to the 5′ and 3′ ends of the
EGFP expression cassette, respectively, as flanking sequences
to facilitate recombination with the HSV-1 genome (Fig. 1D).
Because nucleotide sequences downstream of canonical viral
AAUAAA polyadenylation signals have been shown to
enhance the efficiency of polyadenylation, the 386 bp DraI–
FspI sequence (spanning nt 52,764 to 53,150) was included as
a direct repeat on each side of the EGFP expression cassette
(shown as thick black lines in Fig. 1E).
To generate a recombinant virus expressing EGFP using the
standard marker transfer procedure (Sacks et al., 1985), the
SalI–SalI fragment containing the EGFP cassette was isolated
and co-transfected with infectious wild-type viral DNA.
Recombinant green fluorescent plaques (GFP+) were identified
by fluorescence microscopy, picked and plaque purified five
times. Notably, GFP-negative (GFP−) white plaques were
observed throughout the purification process at frequencies
ranging from 0.3% to 0.9% indicating that the EGFP gene was
continually repressed or lost, presumably by recombination
between the direct repeats (DraI–FspI sequence) flanking the
EGFP expression cassette (thick black lines, Fig. 1E).
Supporting this hypothesis, sectoring of plaques was observed
on rare occasions (Fig. 1F).
The recombinant viral genome was analyzed by Southern
blot analysis (Fig. 1G). Total cellular DNA from Vero cell
monolayers infected with KOS and KOS-CMVGFP was
digested with SalI (to verify the presence or absence of the
EGFP cassette) or KpnI (to verify the site of the insertion).
DNA fragments were separated on an agarose gel, transferred to
a membrane, and hybridized either to (i) P32-labeled DraI–SalI
fragments from HSV-1 genomic DNA (nt 52,764 to 54,826;
HSV probe, Fig. 1G) or (ii) P32-labeled EGFP fragments (GFP
probe, Fig. 1G).
Using the HSV probe, KOS DNA digested with either SalI
or KpnI produced the expected 2.6 and 4.7 kb fragments,
respectively, whereas digestion of KOS-CMVGFP DNA with
each enzyme produced fragments of 4.8 and 6.9 kb, respectively
(Fig. 1G). In addition, weak hybridization to 2.6 and 4.7 kb
fragments was observed in SalI and KpnI KOS-CMVGFP lanes
indicating the presence of low levels of revertant (wild type),
viral genomes. These findings were confirmed using a GFP
Fig. 1. Construction of an EGFP-expressing recombinant of HSV-1, strain KOS. (A) Diagram of the HSV-1 genome showing the UL region flanked by inverted repeats
ab and b′a′ and the US region flanked by inverted repeats a′c′ and ca. (B) Scale in kilobases of the UL26/26.5 and UL27 region. (C) Transcripts of known genes in the
52 to 55 kb region of the HSV-1 genome. Arrows indicate the locations and directions of transcription of individual transcripts; double slash lines indicate breaks in
transcripts, which are initiated outside of the 52 to 55 kb region of the HSV-1 genome; A+ indicates the location of polyadenylation signals for each transcript. (D)
Restriction map of the 52 to 58 kb region of the genome. Numbers are map units in kb. (E) Location of the EGFP expression cassette within the minimally transcribed
intergenic region between UL26/26.5 and UL27. The CMV major immediate early promoter, the EGFP gene and the SV40 polyadenylation signal (late orientation)
are indicated in red, green and yellow, respectively. The predicted transcripts including polyadenylation signals for UL26, UL26.5 and UL27 are shown beneath the
diagram. (F) Loss of fluorescence in 3/4 of a sectioned plaque of KOS-CMVGFP on Vero cell monolayers. Vero cell monolayers were infected at a multiplicity of 0.05
PFU/cell of KOS-CMVGFP for 1 h and overlaid with 2% methylcellulose. At 4 days p.i., plaques were examined by phase contrast microscopy (upper panel) and
fluorescence microscopy (lower panel). (G) Southern blot analysis of KOS and KOS-CMVGFP DNA digested with the restriction enzymes indicated beneath each
blot. Total cellular DNA from Vero cells infected at a multiplicity of 5 PFU/cell was analyzed using either a 32P-labeled HSV-1 DraI to SalI fragment (nt 52,764 to
54,826; left panel) or an AgeI to XbaI of plasmid pEGFP-N1, which contains the EGFP ORF, (right panel) as probe. Molecular weight markers in kb are indicated on
the left.
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6.9 kb fragments of KOS-CMVGFP and not to KOS DNA.
These results are consistent with insertion of the 2.2 kb EGFP
expression cassette into the viral genome between UL26/26.5
and UL27 and indicate that a low level of revertant, GFP− virus
that had lost the EGFP cassette was present in the KOS-
CMVGFP stock.
In vitro replication of KOS-CMVGFP
To examine the effect of the presence of the EGFP
expression cassette on viral replication in vitro, single cycle
growth experiments were performed in Vero cells at a calculated
multiplicity of infection of 0.1 PFU per cell (Fig. 2). KOS andKOS-CMVGFP replicated with nearly identical efficiencies and
kinetics. Similar results were observed at a multiplicity of 2.5
PFU/cell indicating that the recombinant virus is not signifi-
cantly impaired for growth in Vero cells (data not shown).
Acute infection of mice with KOS-CMVGFP
To observe the spread of KOS-CMVGFP in live mice during
the acute phase of infection, animals were infected with 2×105
PFU/eye of recombinant virus via the ocular route following
corneal scarification. Mice were anesthetized daily post-
infection (p.i.) and the eyes, periocular region, and snout were
examined by fluorescence microscopy (Fig. 3). On day 1 p.i.,
fluorescence was observed in eyes as distinct small foci on the
Fig. 3. Expression of EGFP during acute infection of mouse corneas. Two 5- to
6-week-old male ICR mice were infected in both eyes with 2×105 PFU/eye of
KOS-CMVGFP following corneal scarification. The mice were anesthetized
daily p.i. and examined by fluorescence microscopy at 40× magnification. The
results of one of two independent experiments are shown. Days p.i. and area of
the mouse photographed are indicated to the left and bottom, respectively, of the
photomicrographs.
Fig. 2. Single cycle growth curves of KOS and KOS-CMVGFP in Vero cells.
Monolayers of Vero cells were infected at a multiplicity of 0.1 PFU/cell of KOS
or KOS-CMVGFP. Infected cells were incubated at 37 °C and harvested at the
indicated times. Infectious virus was quantified by standard plaque assays on
Vero cell monolayers. The results of one of two independent assays are shown.
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and 3 p.i., and foci grew larger and coalesced resulting in large
dendritic corneal lesions. Maximal intensity and spread of
fluorescence were consistently observed on day 2 p.i. The
intensity and extent of spread of fluorescence declined rapidly
in the eye after day 3 with few or no small ocular foci observed
between days 4 (data not shown) or 5 and 11 p.i.
During the course of acute infection, fluorescent foci in
periocular tissue and the snouts of mice were also observed
(Fig. 3). Foci in periocular tissue were first observed on day 3
p.i., expanded radially from the initial site of fluorescence until
day 7 p.i. and diminished in intensity thereafter. Foci were
initially observed on the snout on day 5 p.i. These foci expanded
radially from the initial site until day 7 or 8 p.i. and diminished
thereafter. Although the general pattern of spread was
consistent, the level and extent of spread of fluorescence varied
considerably among mice. Collectively, these tests confirm the
accepted model that HSV-1 spreads from the cornea to adjacent
sites and that viral spread is time-dependent.
Effects of the presence of the EGFP cassette on acute viral
replication and pathogenesis
(i) Gross pathology
Physical examination of mice acutely infected with KOS and
KOS-CMVGFP revealed little difference in gross pathology
throughout the 30-day test period. Mice in both experimental
groups exhibited moderate to severe symptoms of blephar-
oconjuctivitis, ulcerative lesions, and periocular hair loss.(ii) Viral titers in tear film
To examine the efficiency of acute viral replication at the site
of inoculation in mice, viral titers in tear film were determined
daily for 9 days following corneal inoculation (Fig. 4A). KOS-
CMVGFP replicated to levels slightly lower than wild-type
KOS for the first 2 days p.i. and to similar levels between day 2
and day 4 p.i. From day 4 through day 6 p.i., the levels of KOS-
CMVGFP in tear film were slightly but significantly reduced
with levels 3.5- to 4.5-fold lower than wild type [P=0.002–
0.007, two-tailed t test]. On days 7 through 9, the levels of
KOS-CMVGFP were similar to KOS. Overall, a minor but
Fig. 5. Viral genome loads of KOS and KOS CMVGFP in latently infected TG.
One hundred nanograms of DNA from individual TG or pooled TG cell
suspensions (used to make TG cell culture in Fig. 7) obtained between days 30
and 35 p.i. were analyzed by competitive PCR and compared to competitive
PCR products of HSV-1 genome standards ranging from 1 to 6×104 genome
copies per 100 ng of TG DNA. The numbers (n) of explanted TG or replicate TG
cell suspensions analyzed are shown below the graph. The results shown are the
means±standard errors of the means (error bars).
Fig. 4. Tear film titers of KOS and KOS-CMVGFP during acute infection of
mice. Thirty-three mice per group were infected as described in the legend to
Fig. 3. On the days indicated, eyes were swabbed and viral titers were
determined by standard plaque assays on Vero cell monolayers. (A) Viral titers
are shown as the means±standard error of the means (error bars). Asterisks
indicate significant differences between KOS and KOS-CMVGFP. (B) The
percent of GFP− (revertants) virus over time in tear film are shown as the
means±standard error of the means (error bars).
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viruses [P=0.016, two-way ANOVA] was evident, primarily as
a slight reduction in the levels of KOS-CMVGFP in tear films.
These findings demonstrate that insertion of the EGFP cassette
between the UL26/26.5 and UL27 genes had a slight but
statistically significant effect on the levels of virus in tear film.
In addition to determining the absolute levels of virus
recovered from mouse tear film, the percentage of revertant
(GFP−) virus in KOS-CMVGFP samples was determined by
standard plaque assays (Fig. 4B). The levels of GFP− virus
increased 3.0-fold between days 1 and 4 p.i. [P=0.007, two-
tailed t test], decreased 1.5-fold between days 4 and 6 p.i., and
then increased 2.5-fold through day 9 p.i., when GFP− virus
represented nearly 60% of the virus sample. These observations
indicate that either EGFP activity or the EGFP cassette was
gradually lost during acute replication. Although the decrease in
the amount of GFP− between days 4 and 6 p.i. was not
statistically significant, the timing and magnitude of the
decrease were similar in two independent experiments. Because
the ratios of GFP− to GFP+ virus decreased (Fig. 4B) during a
period of increase in overall viral titer (days 4–6, Figs. 4A and
B) it is possible that some of the virus in tear film on these days
was derived from a distal site (i.e. TG neurons).Effects of the EGFP cassette on the efficiency of establishment
and reactivation of latency
To determine the effects of the presence of the EGFP cassette
in the viral genome on the establishment and reactivation of
latency, mice latently infected with KOS and KOS-CMVGFP
were euthanized between days 30 and 35 p.i. TG were removed
and the efficiency of establishment of latency was determined
by measuring viral genome loads (Fig. 5). The kinetics and
efficiency of reactivation were determined by measuring the
presence of infectious virus in TG explants (Fig. 6) and in TG
cell cultures (Fig. 7).
(i) Viral genome loads
The efficiency of establishment of latency was determined
by measuring viral genome loads in individual explanted TG
and in replicate samples of dissociated TG cells by competitive
PCR (Halford and Schaffer, 2000). As shown in Fig. 5, KOS-
CMVGFP established latency as efficiently as wild-type virus
as assayed in both explanted TG (2.3–2.5×102 genomes/
100 ng TG DNA) and dissociated TG cells (1.1–1.2×103
genomes/100 ng TG DNA) [P=0.66 and 0.29, two tailed t test
of data from explanted TG and dissociated TG cell samples,
respectively]. Based on these findings, the presence of the
EGFP cassette in the viral genome did not significantly affect
the efficiency of establishment of latency.
(ii) Reactivation by explant co-cultivation
Examination of TG latently infected with KOS-CMVGFP
by fluorescence microscopy immediately following explant
revealed no detectable EGFP expression, indicating either that
the EGFP expression cassette was silenced during latency or
Fig. 7. Reactivation of KOS and KOS-CMVGFP in TG cell cultures. TG cell
cultures were prepared by pooling TG infected with KOS-CMVGFP 30 to
35 days p.i., gently teasing them apart, treating with collagenase to generate
single-cell suspensions, and distributing the resulting cell suspensions into
24-well plates. Cultures were examined by fluorescence microscopy at 100× at
(A) day 1 or (B) day 4 post-plating. Apparent neuronal cell bodies are indicated
by red arrows. (C) Efficiencies of reactivation of KOS and KOS-CMVGFP from
TG cell cultures. TG cell cultures were prepared by pooling 12 TG per virus
group as described above. Culture medium was assayed daily for the presence of
infectious virus as indicated by cytopathic effects in indicator plates of Vero
cells. Each point represents the cumulative percentage of reactivating wells from
two experiments. Asterisks indicate significant differences between KOS and
KOS-CMVGFP as determined by Fisher's exact test. The number (n) of TG cell
culture wells is indicated.
Fig. 6. Reactivation of KOS and KOS-CMVGFP in explanted TG. TG from
mice infected 30 to 35 days p.i. with KOS or KOS-CMVGFP were cut into six to
eight pieces and cocultured on Vero cell monolayers. Explant cultures of KOS-
CMVGFP were examined by fluorescence microscopy at 100× (A and C) or
400× (B). (A) Explanted TG on day 1 p.e. A single GFP+ganglionic cell is
indicated by the red arrow. (B) Explanted TG on day 2 p.e. showing morphology
of GFP+cells. Red arrows point to apparent cell bodies of GFP+ ganglionic
neurons. (C) Reactivating TG explant on day 4 post-explant. Orange circle
shows GFP+ Vero cells. (D) Efficiencies of reactivation from explant cultures
of TG latently infected with KOS and KOS-CMVGFP. Explant culture medium
was assayed daily for the presence of infectious virus as indicated by cytopathic
effects in indicator plates of Vero cells. Each point represents the cumulative
percentage of reactivating TG from two experiments. The number (n) of TG per
group is indicated.
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expression in explanted TG was first detected 14 h post-explant
(p.e.) and the intensity of single cell fluorescence increased
through 24 h p.e. (Fig. 6A). High levels of EGFP expression
were maintained thereafter. Notably, cells expressing EGFP
appeared to be neurons as determined by cell morphology (i.e.
large round cell bodies with processes extending outward) (Fig.
6B). Spread of fluorescence, and hence, infectious virus, from
TG to the Vero cell monolayer was observed between days 2
and 10 p.e. (Fig. 6C). Only very rarely were GFP− plaques
observed in the Vero cell monolayer suggesting loss of GFP
expression during viral spread through the monolayer.
The kinetics and efficiency of reactivation of wild-type and
EGFP-containing virus were assayed by explant cocultivation
of latently infected TG (Fig. 6D). The mean time to initial
detection of reactivated virus in culture medium was determined
by averaging the time in days post-explant when infectious
virus was first detected in each reactivation culture. The mean
time (mean±S.D.) to initial detection of reactivated virus in
culture medium was similar for KOS (4.0±1.2 days p.e.) and
KOS-CMVGFP (4.2±1.4 days p.e.) [P=0.49, two-sided t test].
KOS-CMVGFP also reactivated with wild-type frequency in
that 34 of 36 (92%) explanted KOS-CMVGFP TG reactivated
compared to 37 of 40 (94%) of KOS TG by 8 days p.e. [P=1.0,
Fisher's exact test].(iii) Reactivation in TG cell cultures
Reactivation efficiencies were also assessed in TG cell
cultures. An interesting feature of this assay is that differences
in the kinetics and efficiency of reactivation observed by the TG
explant assay are often enhanced in the TG cell culture assay
(Balliet and Schaffer, 2006; Halford and Schaffer, 2001). As for
explanted TG, examination of dissociated TG cells latently
infected with KOS-CMVGFP by fluorescence microscopy
immediately after plating revealed no detectable EGFP
expression. EGFP expression was first detected at 8 h post-
plating (p.p.) with peak fluorescence intensity observed on day
2 p.p. (Fig. 7A). In addition, the greatest number of single
fluorescing neurons expressing EGFP (identified by their
morphology) was observed on day 2 p.p. with 14±4.0 GFP+
and 7.3±3.1 GFP+ neurons/well (mean±S.D.) in two indepen-
dent experiments (n=12 wells/experiment), respectively. A
steady reduction in the number of GFP+ neurons occurred after
day 2 p.p., likely due to cell death. Notably, however, although
7–14 neurons expressed EGFP per well, only one to three
multicell fluorescent foci (i.e. foci of reactivated virus)
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days 2 and 10 p.p. (Fig. 7B). This finding indicates that not all
neurons that initiate transcription of the viral genome are
competent to complete the viral lytic cascade resulting in the
production of infectious virus. Similar to explant cultures, very
rarely were GFP− plaques observed suggesting loss of GFP
expression during viral spread through the culture.
Although, based on morphology, the only cells expressing
GFP following plating appeared to be neurons, immunofluo-
rescence tests were performed to test this hypothesis using a
monoclonal antibody that recognizes the neuron-specific β3
isoform of tubulin, TuJ1 (Ferreira and Caceres, 1992). Dis-
sociated TG cells were plated in the presence of 200 μM
acyclovir, an inhibitor of viral replication and spread that does
not affect the activity of the HCMV-MIEP. Cells were fixed and
stained with the neuronal marker, TuJ1 on days 2 or 4 p.p.
(Fig. 8). In these tests, all cells expressing EGFP were also
TuJ1+. In no instance were EGFP+/TuJ1− cells observed in this
test. These results are consistent with the long held view
(Goodpasture, 1929) that ganglionic neurons are the cell type
that harbors latent viral genomes (Maggioncalda et al., 1996;
Mehta et al., 1995; Sawtell, 1997; Shimeld et al., 2001; Stevens,
1989).
Consistent with previous findings, assays for viral reactiva-
tion in TG cell cultures indicated that the time of initial
detection of reactivated virus was similar in these cultures and
in explant cultures for both viruses (compare Fig. 6D with 7C)
(Balliet and Schaffer, 2006). In TG cell culture, however, KOS
reactivated more rapidly than KOS-CMVGFP (Fig. 7C). On
days 3 and 4 p.p., 13 of 24 (54%) and 18 of 24 (75%) of the
KOS cultures, respectively, reactivated compared to 3 of 24
(12.5%) and 9 of 24 (37.5%) of KOS-CMVGFP cultures. These
differences in reactivation frequencies were statistically signif-Fig. 8. Identification of GFP+ cells in TG cell cultures by immunofluorescence.
TG cell cultures latently infected with KOS-CMVGFP were prepared as
described in Fig. 7 and plated on coverslips in the presence of 200 μM acyclovir
to repress reactivation. On days 2 (data not shown) and 4 p.p., cells were
washed, fixed, permeabilized, and probed with a TuJ1 monoclonal antibody,
which is specific for post-mitotic neurons. Cultures were examined by
fluorescence microscopy at 400× for staining with TuJ1 antibody and for
EGFP expression. Staining of cellular DNA with DAPI was performed to
confirm specificity of TuJ1 antibody.icant [P=0.004 and 0.02, respectively]. Consistent with
this observation, the mean time to reactivation of KOS was
3.6±1.65 days p.p. compared to 4.8±1.9 days p.p. for KOS-
CMVGFP, representing a 1.2 day delay relative to KOS.
Between days 5 and 10 p.p., the percentage of KOS cultures that
reactivated was greater than the percentage of KOS-CMVGFP
cultures culminating with 19 of 24 (79%) of KOS cultures
reactivating by 10 days p.p. compared to 14 of 24 (58%) of KOS-
CMVGFP cultures. Although a trend towards KOS-CMVGFP
reactivating somewhat less efficiently than KOS was evident,
the differences in reactivation frequencies were not statistically
significant [P=0.485 (day 5 p.p.) to 0.65 (day 10 p.p.)] reflecting
the limited power of the test.
Collectively, these findings indicate that EGFP expression in
latently infected ganglionic cells is a reliable marker of neurons
that are able to activate viral lytic promoters, potentially
culminating in viral reactivation. They also show that insertion
of the EGFP cassette between the UL26/26.5 and UL27 genes
affects the kinetics and efficiency of reactivation from latency
minimally in the TG explant model of reactivation but
moderately in the more rigorous TG cell culture model.
Discussion
To examine the nature of virus–host interactions and to study
the mechanisms underlying viral latency and reactivation, a
recombinant HSV-1 virus that expresses EGFP during produc-
tive infection (KOS-CMVGFP) was generated and character-
ized. The results of these tests demonstrate that insertion of the
EGFP expression cassette between UL26/26.5 and UL27 genes
did not grossly impair viral replication in vitro or in vivo nor did
it affect the efficiency of establishment of latency. Only under
rigorous ex vivo conditions used to assay viral reactivation was
a phenotype for KOS-CMVGFP apparent. These studies also
demonstrate the usefulness of the fluorescent reporter as an
early marker of neurons capable of supporting HSV-1
reactivation.
Strategy for constructing KOS-CMVGFP
The strategy for the construction of the EGFP-expressing
recombinant virus was based on two criteria. First, the expres-
sion cassette must constitutively express EGFP to high levels.
Second, insertion of the EGFP expression cassette into the viral
genome must not adversely affect the functions of viral genes or
cis-acting elements.
We chose the HCMV-MIEP because of its high level of
constitutive expression and because its activity is unaffected by
common antiviral compounds (e.g. acyclovir). Specifically, we
selected the HCMV-MIEP from the expression vector pCB6
(Brewer and Roth, 1991). This choice was based on findings
from transient transfection assays comparing the levels of viral
and cellular proteins transiently expressed from pCB6 and
the widely used, commercially available expression vector,
pcDNA3 (Invitrogen, Carlsbad, CA). Consistently, 2- to 3-fold
higher levels of viral and cellular proteins were expressed in
cells transiently transfected with pCB6 constructs than in cells
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unpublished observations). This is likely due to the fact that the
HCMV-MIEP in pCB6 is considerably larger than the IEP in
pcDNA3. In addition, to ensure that transcripts from the EGFP
expression cassette were efficiently processed and polyadeny-
lated, we appended the highly efficient and well-characterized
SV40 late polyadenylation signal to the EGFP ORF (Hans and
Alwine, 2000, and references therein).
We chose to insert the EGFP expression cassette between the
UL26/26.5 and UL27 genes because (i) this region of the viral
genome appears to be transcriptionally inert (Bzik et al., 1984;
Holland et al., 1984; Liu and Roizman, 1991) and (ii) insertion of
the ICP0 gene at this site resulted in stable expression of
functional ICP0 in mutant virus 171 (Cai et al., 1993). Although
in that study insertion at this location was stable, the EGFP
cassette in our recombinant virus was continually lost at a low
but measurable rate. The difference in stabilities of the inserted
genes in 171 (ICP0) and KOS-CMVGFP (EGFP) is likely due to
differences in the effects of insertion of the cassette on the fitness
of the recombinant virus. Insertion of the ICP0 gene conferred a
selective advantage on 171 relative to the parental ICP0− double
mutant virus whereas insertion and expression of the nonviral
EGFP gene likely conferred a selective disadvantage on KOS-
CMVGFP relative to the wild-type virus. Loss of EGFP expres-
sion in a recombinant HSV-1 virus is not unique to KOS-
CMVGFP. Infrequent loss of EGFP expression was also
observed when an EGFP expression cassette was inserted bet-
weenUL53 andUL54 in the KOS genome (Foster et al., 1999). In
this case, however, while the EGFP cassette was retained, expres-
sion of EGFP was repressed (T. Foster, personal communication).
Effects of the EGFP expression cassette on acute infection of
mice
Tear film titers of mice infected with KOS-CMVGFP were
slightly but significantly lower than wild-type virus indicating
that insertion of the EGFP expression cassette into the viral
genome had a minor but detectable effect on virus replication
during the acute phase of infection. Like wild-type virus,
however, titers of KOS-CMVGFP in tear film exhibited a
biphasic curve. The first peak is thought to consist of virus
produced primarily in the eye, the site of primary infection. The
second peak is thought to, but has not been demonstrated
directly, consist of “round trip” virus produced in the TG and
transported back to the eye and periocular tissue.
Two findings from this study support the round trip model.
First, the finding that peak spread and intensity of fluorescence
of infected ocular cells correlated with peak viral titers on day 2
but not on day 6 p.i., the timing and occurrence of the second
peak of infectious virus, strongly suggesting that virus produced
in TG is transported to and accumulates in the eye. Second, after
a steady increase in the percentage of GFP− virus in tear film
during the first 4 days of infection, an appreciable drop in
the percentage of GFP− virus was observed between days 5
and 6 p.i. indicating an increase in the amount of GFP+ KOS-
CMVGFP virus. Because it is improbable that revertant GFP−
viruses incorporated the EGFP expression cassette by geneticrecombination, the additional GFP+ virus was likely produced
at a distal site.
The most likely distal source of virus is cells of the TG.
Consistent with the role of ganglionic cells as the source of
GFP+ virus found in the eye at day 6 p.i., a correlation exists
between (i) the number of GFP+ HSV-1-infected cells in the TG
and the second peak of virus in tear film (Shimeld et al., 2001; J.
W.B. and P.A.S., unpublished observations), and (ii) the time of
peak titers of virus in TG and the second peak of virus in tear
film (Balliet and Schaffer, 2006).
During the course of acute infection, significant spread of
virus from the eyes to periocular tissue and skin of the snout and
nose was observed, demonstrating the usefulness of KOS-
CMVGFP as a tool for studying zosteriform spread of HSV-1 in
mice. Summers et al. have elegantly demonstrated zosteriform
spread of virus from eyes to periocular tissue using recombinant
HSV-1 viruses expressing luciferase (Summers et al., 2001);
however, virus spread to the skin of the snout and nose
following ocular inoculation has not been described previously.
While mechanical spread of virus by transfer of tear film by
scratching cannot be ruled out, zosteriform spread is likely a
significant mechanism of virus spread to these distal sites. This
notion is supported by the observations that (i) fluorescent foci
consisted of expanding circles rather than scratch-induced
streaks; (ii) EGFP expression in the skin of the snout and nose
was observed consistently at 4 or 5 days p.i. Thus, the delay in
the appearance of virus reflected the amount of time required for
transport of virus from the eye to the TG and then to epidermal
cells of the snout and nose; (iii) uniform distribution of
fluorescent foci on the snout was evident as shown in Fig. 3 and
virus spread was restricted only to sites innervated by the
maxillary nerve branch; and (iv) virus replication and spread
from central foci appeared to occur beneath the skin.
Effects of the EGFP expression cassette on the establishment
and reactivation of latency
KOS-CMVGFP established latency in ICR mice as efficient-
ly as wild-type virus, consistent with our findings in C57BL/6
and BALB/c mice (Halford et al., 2004). Moreover, no
significant difference in the kinetics or efficiency of reactivation
in latently infected, explanted TG between KOS-CMVGFP and
wild type virus was observed. Using a more sensitive ex vivo
model of reactivation, however, KOS-CMVGFP reactivation
was delayed compared to wild-type virus on days 3 and 4 post-
plating of TG cells and exhibited a moderate 33% and 26%
reduction in reactivation efficiency on days 5 and 10 post-
plating, respectively. Thus, the EGFP expression cassette had a
noticeable effect on viral reactivation under stringent assay
conditions (i.e. in the TG cell culture model).
Regardless of the reactivation model, GFP fluorescence was
not observed during latency, but was observed 8 to 14 h
following plating of TG cells or explant of TG, respectively.
This observation is consistent with previous findings that the
HCMV-MIEP is silenced during viral latency (Ecob-Prince et
al., 1995; Lachmann et al., 1996; Wilson et al., 1999) although
the degree of repression may be dependent on where the
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(Palmer et al., 2000). Notably, EGFP expression in both ex vivo
models preceded detection of infectious virus by more than 24 h
and can thus serve as a sensitive marker of latently infected
neurons some of which are in the early stages of initiating viral
lytic gene expression, which by definition, precedes reactiva-
tion. Moreover, when first detected, EGFP expression was
localized to sensory neurons of the TG, supporting the
previously published conclusion that HSV-1 latency and
reactivation occur only in sensory neurons (Maggioncalda et
al., 1996; Mehta et al., 1995; Sawtell, 1997; Shimeld et al.,
2001; Stevens, 1989). It is intriguing that on average 7 to 14
neurons out of an average of 500 neurons per well (Halford et
al., 1996; Halford and Schaffer, 2001) expressed EGFP within
the first 3 days post-plating in TG cell cultures. Of these, only
one to three EGFP+ neurons were able to support reactivation as
determined by spread of fluorescence from a single EGFP+
neuron to surrounding support cells. Thus, although transcrip-
tion of the viral genome is initiated in a number of latently
infected neurons, only a subset of these neurons is competent to
support the extensive program of viral gene expression that
leads to reactivation. The reason for this is currently unknown
but may be due to differences in the activities of cellular stress-
induced signaling pathways induced or repressed in cells that
support or do not support reactivation. Alternatively, only
distinct types of sensory neurons may be competent to support
efficient viral reactivation from latency (LaVail et al., 1993;
Margolis et al., 1992a; Yang et al., 2000).
In this study KOS-CMVGFP yielded novel insights into
acute phase replication and viral reactivation from latency. In
addition, it has proven useful in understanding mouse strain-
specific resistance to HSV-1 (Halford et al., 2004). Currently,
we are testing compounds that inhibit or induce viral
reactivation using TG cell cultures latently infected with
KOS-CMVGFP. We are also examining the basis for the
reduced pathogenicity and impaired reactivation efficiency of
the DoriL-ILR mutation in the KOS-CMVGFP background
(Balliet and Schaffer, 2006), a virus containing point mutations
in HSV-1 oriL that inhibit initiation of viral DNA replication
from this origin (Balliet et al., 2005).
Materials and methods
Cells and viruses
Vero (ATCC CCL-81; Yasmura and Kawakita, 1963) and
293 cells (ATCC CRL-1573; Graham et al., 1977) were
propagated in Dulbecco's modified Eagle's medium (DMEM)
supplemented with 10% fetal calf serum (FCS), penicillin (100
units/ml), streptomycin (100 μg/ml), and 2 mM L-glutamine.
The wild-type virus used in this study was HSV-1 strain KOS at
p11 from original isolation (Smith, 1964).
Plasmids
Cloning vectors used in the construction of plasmid
pGFP53K, which contains the backbone for introducing theEGFP expression cassette (Fig. 1E) into the viral genome by
marker transfer (Sacks et al., 1985), were generated as follows.
Plasmid pBUC-2 was generated by ligation of annealed
oligonucleotides OJB5 [5′-AAT TCG TCG ACA GGC CTA
GAT CTT CTA GATACG TAT GGC CAG AGC TCA-3′] and
OJB6 [5′-AGC TTG AGC TCT GGC CAT ACG TAT CTA
GAA GAT CTA GGC CTG TCG ACG-3′] into pUC8 digested
with EcoRI and HindIII. In this way, the polylinker of pUC8
was replaced with a different polylinker containing the
following unique restriction enzyme cleavage sites (5′ to 3′):
EcoRI, SalI, StuI, BglII, XbaI, SnaBI, MscI, SacI, and HindIII.
Likewise, plasmid pBUC-3 was generated by ligation of
annealed oligonucleotides OJB8 [5′-AAT TCA GAT CTT
CTA GAA GGC CTT GGC CAG TCG ACA-3′] and OJB9 [5′-
AGC TTG TCG ACT GGC CAA GGC CTT CTA GAA GAT
CTG-3′] into pUC8 digested with EcoRI and HindIII. The
polylinker of pBUC-3 contains the following unique restriction
enzyme cleavage sites (5′ to 3′): EcoRI, BglII, XbaI, StuI,
MscI, SalI, and HindIII.
Plasmid pGFP53K was constructed as follows. The CMV
promoter from plasmid pEGFP-N1 (Clontech, San Francisco,
CA) was removed to produce plasmid pEGFPΔCMV by self-
ligation after digestion with AseI and NheI and blunt-ending
both ends using Klenow. A 0.75 kb TspRI (blunt-ended with T4
DNA polymerase) to XmnI fragment containing the CMV
promoter from plasmid pCB6 (Brewer and Roth, 1991) was
ligated into pEGFPΔCMV digested with SmaI to generate
plasmid pEGFP6. Plasmid pSK (Cai et al., 1993) was digested
with SalI and FspI (nt 52,192–53,150, Figs. 1D and E) to
generate a 0.96 kb fragment which was cloned into plasmid
pEGFP6 digested with ApaI (blunt-ended with T4 DNA
polymerase) and SalI to generate plasmid pUL26EGFP6. A
0.27 kb XbaI to EcoRI (blunt-ended with Klenow) containing
the SV40 late polyadenylation signal from plasmid pUPAS
(Carswell and Alwine, 1989; Schek et al., 1992) was ligated into
pBUC-3 digested with XbaI and StuI. This plasmid was then
digested with MscI and SalI and ligated with a 2.1 kb DraI to
SalI (nt 52,764–54,826, Figs. 1D and E) fragment from plasmid
pSK to generate plasmid pBUCpAUL27. Plasmid pGFP53K
was assembled by three-way ligation of a 2.5 kb SalI to XbaI
fragment containing HSV-1 UL26 sequences, the CMV
promoter, and the EGFP gene from plasmid pUL26EGFP6,
and a 2.3 kb XbaI to HindIII fragment containing the SV40
polyadenylation signal and HSV-1 UL27 sequences from
plasmid pBUCpAUL27 into vector pBUC-2 digested with
SalI and HindIII.
Construction of mutant and rescuant viruses
Recombinant KOS-CMVGFP virus was generated by
marker transfer of a fragment containing the EGFP expression
cassette in pGFP53K into infectious wild-type HSV-1 DNA
(Sacks et al., 1985). Specifically, 1×106 293 cells in a
100 mm dish were co-transfected with the 4.8 kb SalI to SalI
fragment (Fig. 1E) from pGFP53K and infectious KOS DNA
using Lipofectamine 2000 (Invitrogen) as per the manufac-
turer's instructions. Transfected monolayers were frozen at
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cells were scraped into medium, cell suspensions were
transferred into tubes, sonicated, and clarified by centrifuga-
tion (800×g for 10 min). Serial dilutions of infectious virus in
the resulting supernatant fluid were used to infect Vero cell
monolayers (2×105 cells) in 35 mm dishes for 1 h. Vero cell
monolayers were washed once with PBS and overlaid with
2% methylcellulose. Four days post-infection, plaques were
examined by fluorescence microscopy with a Nikon Eclipse
TE300 inverted fluorescence microscope (Nikon Instruments,
Lewisville, TX) and individual GFP+ plaque isolates were
picked, amplified, and screened by Southern blotting
(described below) for the presence of the EGFP expression
cassette. Among several candidate KOS-CMVGFP viruses, a
single virus was plaque purified five times and used in
functional studies.
Southern blot analysis
Southern blots were performed as described previously
(Balliet et al., 2005). Briefly, 8×105 Vero cells in 60 mm
dishes were infected at a multiplicity of 5 PFU per cell. When
cytopathic effects were generalized, cells were scraped into
medium, cell suspensions were transferred to tubes, and
centrifuged. Cell pellets were lysed and the DNA in the lysate
was isolated. Three micrograms of total infected cell DNA
was digested with restriction enzymes. The resulting frag-
ments were separated on 0.8% agarose gels and transferred
to nylon membranes, prehybridized for 1 h at 68 °C in
ExpressHyb solution (Clontech, San Francisco, CA) and
hybridized for 1 h at 68 °C using 32P-labeled random-primed
probes specific for the DraI–SalI fragment of HSV-1 DNA
(nt 52,764 to 54,826) or for the AgeI–XbaI fragment
of plasmid pEGFP-N1, which contains the EGFP ORF.
The blots were washed as per the manufacturer's instructions
and the hybridized membrane was exposed on a Phosphor-
Imager cassette (Molecular Dynamics, Sunnyvale, CA)
overnight.
Viral growth curves
Vero cells (2×105) were plated in 35 mm dishes. The cells
were counted 24 h after plating and infected at a calculated
multiplicity of 0.1 or 2.5 PFU per cell of KOS or KOS-
CMVGFP. Following 1 h adsorption at 37 °C, the inoculum
was removed, cells were washed 3× with PBS, and growth
medium was added back to each culture. The actual titers of
viral inocula were determined by standard plaque assays on
Vero cell monolayers and are shown as the 0 h time point in
Fig. 2. Viral inocula did not differ by more than 2-fold
between viruses. Infected monolayers were frozen at −80 °C
at the indicated times p.i. Cultures were later thawed, cells
were scraped into medium, cell suspensions were transferred
into tubes, sonicated, and clarified by centrifugation (800×g
for 10 min). Levels of infectious virus in supernatant fluids
were determined by standard plaque assays on Vero cell
monolayers.Inoculation of mice
Five- to six-week-old (∼30 g) male ICR mice (Harlen
Sprague–Dawley, Indianapolis, IN) were handled in accordance
with The Guide for the Care and Use of Laboratory Animals
(NIH Publication no. 85-23, revised 1996) and the guidelines of
the Institutional Animal Care and Use Committee of the Beth
Israel Deaconess Medical Center. Mice were distributed
randomly into two groups and anesthetized by intraperitoneal
(i.p.) administration of xylazine (9 mg/kg of body weight) and
ketamine (100 mg/kg). Mouse corneas were scarified with a 26-
gauge needle, tear film was blotted, and 2×105 PFU of virus in
3 μl of complete DMEM was placed on each eye as described
previously (Halford and Schaffer, 2000). The titers of virus in
inocula were confirmed by standard plaque assays on Vero cell
monolayers and were found to differ by less than 2-fold.
Analysis of viral replication and spread in mice
Examination of mice by fluorescence microscopy was
performed as follows. Two mice infected with KOS-CMVGFP
were anesthetized at the same time each day from 1 through
11 days p.i. Images of infected areas of mice were captured at
40× magnification with a Nikon Eclipse TE300 inverted
fluorescence microscope, photographed with an RT Slider
digital camera (Diagnostic Instruments, Sterling Heights, MI)
and assembled with Photoshop software (Adobe Systems, Inc.,
Mountain View, CA).
To determine viral titers in tear film, tear film samples were
collected from both eyes using a single cotton-tipped applicator.
The cotton tip was transferred to 500 μl complete DMEM and
frozen at −80 °C. Frozen samples were later thawed, thoroughly
mixed, and infectious virus was quantified by standard plaque
assays on Vero cell monolayers. The total number of PFU/
cotton tip was determined and divided by 2 to calculate the
average viral titer per eye.
Measurement of viral genome loads in TG by competitive PCR
The competitive PCR assay used in these tests has been
described previously (Halford and Schaffer, 2000). Briefly, total
DNA was isolated from individual latently infected TG
harvested 30 to 35 days post-inoculation using the Qiamp
DNA mini kit (Qiagen, Hilden, Germany) as per the manufac-
turer's instructions. Oligonucleotide primers specific for the
HSV-1 ribonucleotide reductase (RR) gene (UL39) and
competitor templates were used, amplifying 243- and 322-bp
fragments, respectively, from each template. Included in each
assay were control samples containing known numbers of viral
genomes. The PCR products were vacuum slot blotted in
duplicate, hybridized to oligonucleotide probes specific for
either HSV RR or competitor templates, and the relative yields
of the two PCR products were determined by PhosphorImager
analysis. A standard curve was plotted as the ratio of HSV RR to
competitor as a function of the number of viral genomes. The
viral genome load per TG was calculated as the number of
genomes per 0.1 μg of TG DNA.
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To measure reactivation by explant cocultivation, mice were
euthanized 30 to 35 days post-inoculation by CO2 asphyxiation.
Latently infected TG were removed immediately, cut into six to
eight equal-sized pieces, and cocultivated with 3×104 Vero
cells in 1.5 ml of complete DMEM per well in 24 well plates.
Each day p.e., 150 μl of medium was removed and assayed for
the presence of infectious virus. Fresh complete DMEM
(500 μl) was added to TG explant cultures every third day.
The presence of infectious virus and hence, reactivation, was
detected by transferring the 150 μl sample of explant medium to
fresh Vero cell monolayers and scoring daily for cytopathic
effects.
Measurement of reactivation in primary, latently infected TG
cell cultures was performed as described previously (Halford
et al., 1996; Halford and Schaffer, 2001). Briefly, on day 30
post-inoculation, latently infected mice were euthanized and TG
were removed (n=3 mice or 6 TG per virus). Individual TG
were teased apart longitudinally using a scalpel. All 6 teased TG
latently infected with each virus were pooled, incubated in
1.2 ml of 0.1% collagenase (Sigma) in Hanks' balanced salt
solution for 40 min at 37 °C, and then 7 ml TG growth medium
(MEM supplemented with 10% FCS, 0.15% HCO3
−, penicillin
(100 units/ml), streptomycin (100 μg/ml), 2 mM L-glutamine,
and 10 ng/ml NGF) was added. Dissociated TG cells were
washed three times, resuspended in TG medium, and plated in
24 well collagen-coated plates seeded the previous day with
3×104 uninfected TG feeder cells. Six TG yield 12 ml of TG
cell suspension, which was plated in a 24 well plate at 1 ml/well,
or one-half TG/well. TG cell cultures were tested daily for the
presence of infectious virus as described for explant cultures.
The mean time to detection of reactivated virus was performed
as described for TG explants.
Images of ex vivo cultures were captured as described above.
Magnification is indicated in the legends for the figures.
Immunofluorescence of TG cell cultures
At 30 to 35 days p.i., TG from mice infected with KOS-
CMVGFP were excised and plated on collagen-coated 12-mm
coverslips with 3×104 uninfected TG feeder cells per well of a
24 well plate, in the presence of 200 μM acyclovir. The
cultures were incubated at 37 °C with 5% CO2 for 2 or 4 days
p.p. All subsequent steps were carried out at room temperature.
The cultures were washed twice with PBS, fixed with 4%
paraformaldehyde in PBS (pH 7.4) for 15 min, washed with
PBS for 5 min, then blocked and permeabilized in block
solution (PBS; 5% goat serum, 0.1% Triton X-100) for 1 h.
TuJ1 monoclonal antibody (Covance, Berkeley, CA) was
applied in block solution at a dilution of 1:5000 for 1 h. The
cultures were washed with PBS three times for 5 min.
Rhodamine Red-X-conjugated secondary antibody (Jackson
ImmunoResearch, West Grove, PA) was diluted 1:300 in 1.5%
goat serum in PBS and incubated for 1 hr in a dark, humidified
chamber. The cultures were washed in PBS three times for
5 min, stained with DAPI, rinsed with distilled water andmounted on glass slides with ProLong Antifade (Molecular
Probes, Eugene, Oregon).
Statistics
The statistical tests used in this study are those recommended
by Richardson and Overbaugh (2005). Data are presented as the
mean± standard error of the mean (S.E.M.). Two-way ANOVA
was used to determine the significance of differences among
experimental groups at multiple time points. Linear regression
was used to evaluate the reliability of the standard curves for
competitive PCR. The significance of differences in mean time
to reactivation was determined by two-tailed t test. The
significance of differences in reactivation efficiencies were
determined by Fisher's exact test.
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